射血分数保留的心力衰竭试验中患者选择的难题：探索聚焦表型分析的益处与风险 - Suppr | 超能文献

The Conundrum of Patient Selection in Trials of Heart Failure With Preserved Ejection Fraction: Exploring the Benefits and Risks of Focused Phenotyping.

作者信息

Plehn Jonathan F

机构信息

Cardiovascular-Metabolic-Endocrine-Renal Division, Covance Inc., Princeton, New Jersey.

出版信息

J Card Fail. 2017 Jul;23(7):525-527. doi: 10.1016/j.cardfail.2017.05.013. Epub 2017 May 22.

DOI:10.1016/j.cardfail.2017.05.013

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

The Conundrum of Patient Selection in Trials of Heart Failure With Preserved Ejection Fraction: Exploring the Benefits and Risks of Focused Phenotyping.射血分数保留的心力衰竭试验中患者选择的难题：探索聚焦表型分析的益处与风险

J Card Fail. 2017 Jul;23(7):525-527. doi: 10.1016/j.cardfail.2017.05.013. Epub 2017 May 22.

2

Optimal Eligibility Criteria for Trials in Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭试验的最佳入选标准

J Card Fail. 2017 Jul;23(7):528-529. doi: 10.1016/j.cardfail.2017.05.017. Epub 2017 May 29.

3

Assessing the Eligibility Criteria in Phase III Randomized Controlled Trials of Drug Therapy in Heart Failure With Preserved Ejection Fraction: The Critical Play-Off Between a "Pure" Patient Phenotype and the Generalizability of Trial Findings.评估射血分数保留的心力衰竭药物治疗 III 期随机对照试验的纳入标准：“纯”患者表型与试验结果普遍性之间的关键博弈。

J Card Fail. 2017 Jul;23(7):517-524. doi: 10.1016/j.cardfail.2017.04.006. Epub 2017 Apr 18.

4

[How to evaluate and treat heart failure with preserved left ventricular ejection fraction].[如何评估和治疗左心室射血分数保留的心力衰竭]

Therapie. 2009 Mar-Apr;64(2):101-9. doi: 10.2515/therapie/2009012. Epub 2009 Aug 11.

5

Randomized double-blind placebo-controlled trial of perhexiline in heart failure with preserved ejection fraction syndrome.哌克昔林治疗射血分数保留的心衰综合征的随机双盲安慰剂对照试验

Future Cardiol. 2014 Nov;10(6):693-8. doi: 10.2217/fca.14.62.

6

Quality of inclusion criteria in the registered clinical trials of heart failure with preserved ejection fraction: Is it time for a change?射血分数保留的心力衰竭注册临床试验纳入标准的质量：是否是时候改变了？

Int J Cardiol. 2018 Mar 1;254:210-214. doi: 10.1016/j.ijcard.2017.12.025. Epub 2017 Dec 15.

7

Ranolazine for the treatment of pulmonary hypertension associated with heart failure with preserved ejection fraction: A pilot study.雷诺嗪治疗射血分数保留的心力衰竭相关性肺动脉高压：一项初步研究。

J Heart Lung Transplant. 2016 Nov;35(11):1370-1373. doi: 10.1016/j.healun.2016.07.015. Epub 2016 Jul 27.

8

Four pillars of heart failure: contemporary pharmacological therapy for heart failure with reduced ejection fraction.心力衰竭的四大支柱：射血分数降低的心力衰竭的当代药物治疗

Open Heart. 2021 Mar;8(1). doi: 10.1136/openhrt-2021-001585.

9

[Heart failure with preserved ejection fraction].

Rev Med Interne. 2008 Jun;29 Suppl 1:S6-7. doi: 10.1016/j.revmed.2008.03.022. Epub 2008 May 8.

10

Drug Development for Heart Failure With Preserved Ejection Fraction: What Pieces Are Missing From the Puzzle?射血分数保留的心力衰竭的药物研发：拼图中还缺哪些板块？

Can J Cardiol. 2017 Jun;33(6):768-776. doi: 10.1016/j.cjca.2017.03.013. Epub 2017 Mar 25.

引用本文的文献

1

Spironolactone Reduces the Risk of Death in Veterans With Heart Failure With Preserved Ejection Fraction.螺内酯降低射血分数保留的心力衰竭退伍军人的死亡风险。

J Am Heart Assoc. 2024 Jul 16;13(14):e032231. doi: 10.1161/JAHA.123.032231. Epub 2024 Jul 9.

2

Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease, and Heart Failure with Preserved Ejection Fraction: A Cardiopulmonary Perspective.阻塞性睡眠呼吸暂停、慢性阻塞性肺疾病与射血分数保留的心力衰竭：心肺视角

Am J Respir Crit Care Med. 2020 Feb 15;201(4):500. doi: 10.1164/rccm.201909-1780LE.